Clonidine use and abuse among methadone program applicants and patients

Area of Science:

• Pharmacology
• Addiction Medicine
• Public Health

Background:

• Clonidine is a medication prescribed for hypertension and other conditions.
• Abuse of clonidine, particularly among individuals in methadone treatment, is a growing concern.
• Understanding patterns of clonidine misuse is crucial for patient safety and effective treatment.

Purpose of the Study:

• To investigate the distinct patterns of clonidine use among applicants and patients in methadone treatment programs.
• To identify the motivations, sources, and perceived addictiveness of clonidine among these groups.

Main Methods:

• A survey was conducted with 48 consecutive applicants and 30 known clonidine-abusing methadone patients across three treatment programs.
• Data collected included reasons for use, methods of acquisition, dosage, and beliefs about clonidine's addictive potential.

Main Results:

• Two patterns emerged: applicants primarily used clonidine for opioid withdrawal and sedation, obtaining it from physicians (average dose 0.37 mg).
• Methadone patients used clonidine for psychoactive effects and opioid withdrawal, acquiring it illicitly (average dose 0.6 mg) and largely believing it to be addictive.
• A significant minority of applicants also perceived clonidine as addictive.

Conclusions:

• Distinct patterns of clonidine use exist between methadone applicants and patients.
• The psychoactive use and higher dosage among patients, coupled with illicit acquisition, highlight a significant abuse potential.
• Further research into identifying and treating clonidine abuse within methadone treatment populations is warranted due to overdose risks.